HALO Halozyme Therapeutics PE ratio, current and historical analysis
As of Jan 21, 2025, the HALO stock has a P/E ratio of 18.22. The calculation is based on the latest EPS of $3.07 and the stock price of $55.94 per share. The PE ratio currently is comparable to its last 4-quarter average.
HALO PE ratio history
The mean historical PE ratio of Halozyme Therapeutics over the last eight years is 32.3. The current 18.22 price-to-earnings ratio is 44% less than the historical average. Analyzing the last eight years, HALO's PE ratio reached its highest point in the Sep 2020 quarter at 146, with a price of $26.28 and an EPS of $0.18. The Mar 2022 quarter saw the lowest point at 12.95, with a price of $39.88 and an EPS of $3.08.
Halozyme Therapeutics PE ratio by year
Maximum annual increase: 173.47% in 2022
Maximum annual decrease: -68.73% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 17.35 | -54.88% |
| 2022 | 38.45 | 173.47% |
| 2021 | 14.06 | -68.73% |
| 2020 | 44.96 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | 44.04 | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
HALO average PE ratio chart
The current PE ratio of HALO is under its 3, 5 and 10-year averages.
HALO PE vs peers
HALO's PE ratio is below its peer stocks LLY and JNJ. Halozyme Therapeutics's current PE ratio of 18.22 is less than the average of its peers, which is 53.76.
| Stock name | PE ratio | Market cap |
|---|---|---|
| HALO Halozyme Therapeutics Inc | 18.03 | $7.04B |
| JNJ Johnson & Johnson | 23.94 | $347.52B |
| PFE Pfizer Inc | 34.35 | $147.94B |
| MNKD Mannkind Corp | 76.63 | $1.69B |
| LLY ELI LILLY & Co | 81.31 | $717.11B |
| BAX Baxter International Inc | 151.19 | $16.21B |
Frequently asked questions
What is Halozyme Therapeutics's PE ratio?
As of Jan 21, 2025, HALO stock has a price to earnings ratio of 18.22.
What is the 3-year average PE ratio for Halozyme Therapeutics (HALO)?
Over the last 3 years, the average PE ratio for HALO stock is 21.49.
What is the 5-year average PE ratio for Halozyme Therapeutics (HALO)?
Over the last 5 years, the average PE ratio for HALO stock is 30.45.
What is the highest PE ratio for HALO?
Over the last eight years, the quarterly PE ratio reached its highest level at 146 in the Sep 2020 quarter.
How does the current PE ratio for HALO compare to its historical average?
HALO's current price to earnings ratio is 44% below its 8-year historical average.
How is HALO's PE ratio calculated (Halozyme Therapeutics PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jan 21, 2025), Halozyme Therapeutics's share price is $55.94. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $3.07. Therefore, Halozyme Therapeutics's price to earnings ratio for today is 18.22. PE RATIO(18.22) = STOCK PRICE($55.94) / TTM EPS($3.07)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.